Association between platelet count and the risk of bleeding among patients with nonvalvular atrial fibrillation taking dabigatran after radiofrequency ablation: a cohort study | Zendy

Yurong Xiong | Zendy; Wei Zhou | Zendy; Minghui Li | Zendy; Tao Wang | Zendy; Xiao Huang | Zendy; Huihui Bao | Zendy; Xiaoshu Cheng | Zendy

Open Access

Association between platelet count and the risk of bleeding among patients with nonvalvular atrial fibrillation taking dabigatran after radiofrequency ablation: a cohort study

Author(s) -

Yurong Xiong,

Wei Zhou,

Minghui Li,

Tao Wang,

Xiao Huang,

Huihui Bao,

Xiaoshu Cheng

Publication year - 2020

Publication title -

cardiovascular diagnosis and therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.83

H-Index - 22

eISSN - 2223-3660

pISSN - 2223-3652

DOI - 10.21037/cdt-20-645

Subject(s) - medicine , dabigatran , atrial fibrillation , radiofrequency ablation , cohort , cardiology , ablation , platelet , catheter ablation , warfarin

A reduction in platelet count or function can be a risk factor for bleeding in anticoagulated patients. However, the association between platelet count and the risk of bleeding among nonvalvular atrial fibrillation (NVAF) patients taking dabigatran remains unclear. The aim of this study was to investigate the relationship between platelet count and the risk of bleeding among patients with NVAF taking dabigatran after radiofrequency ablation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research